News



Back


09/01/2015
KURMA Partners invests in Orphazyme ApS
KURMA Partners invests in Orphazyme ApS, a leading European biopharmaceutical company developing Heat Shock Protein based treatment for lysosomal storage diseases and [...]

Download the pdf file







FOLLOW US



contact@kurmapartners.com

Tél: +33 (0)1 84 86 08 61

24, rue Royale
75008 Paris
France

© Copyright KURMA PARTNERS.       LEGAL NOTICE       Terms and conditions       REGULATORY INFORMATION     PRIVATE POLICY     Design : AGENCE K2

X

X